These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
582 related articles for article (PubMed ID: 23394097)
1. Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. Dongiovanni P; Anstee QM; Valenti L Curr Pharm Des; 2013; 19(29):5219-38. PubMed ID: 23394097 [TBL] [Abstract][Full Text] [Related]
2. Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis. Dongiovanni P; Romeo S; Valenti L Biomed Res Int; 2015; 2015():460190. PubMed ID: 26273621 [TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma. Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237 [TBL] [Abstract][Full Text] [Related]
5. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls. Valenti L; Rametta R; Ruscica M; Dongiovanni P; Steffani L; Motta BM; Canavesi E; Fracanzani AL; Mozzi E; Roviaro G; Magni P; Fargion S BMC Gastroenterol; 2012 Aug; 12():111. PubMed ID: 22898488 [TBL] [Abstract][Full Text] [Related]
6. Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis. Carlsson B; Lindén D; Brolén G; Liljeblad M; Bjursell M; Romeo S; Loomba R Aliment Pharmacol Ther; 2020 Jun; 51(12):1305-1320. PubMed ID: 32383295 [TBL] [Abstract][Full Text] [Related]
8. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. Wang CW; Lin HY; Shin SJ; Yu ML; Lin ZY; Dai CY; Huang JF; Chen SC; Li SS; Chuang WL Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282 [TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Sookoian S; Pirola CJ Hepatology; 2011 Jun; 53(6):1883-94. PubMed ID: 21381068 [TBL] [Abstract][Full Text] [Related]
15. Effect of the patatin-like phospholipase domain containing 3 gene (PNPLA3) I148M polymorphism on the risk and severity of nonalcoholic fatty liver disease and metabolic syndromes: A meta-analysis of paediatric and adolescent individuals. Li J; Hua W; Ji C; Rui J; Zhao Y; Xie C; Shi B; Yang X Pediatr Obes; 2020 Jun; 15(6):e12615. PubMed ID: 32020770 [TBL] [Abstract][Full Text] [Related]
16. New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver disease. Barbara M; Scott A; Alkhouri N Hepatobiliary Surg Nutr; 2018 Oct; 7(5):372-381. PubMed ID: 30498712 [TBL] [Abstract][Full Text] [Related]